Eyenote Plus Eye Drops contain Boric Acid (2% w/v) + Sodium Chloride (2% w/v) + Sulphacetamide (12.5% w/v) + Zinc Sulfate (0.1% w/v), a multi-action antibacterial ophthalmic formulation used for bacterial eye infections, redness, discharge, and ocular irritation.
Sulphacetamide provides broad-spectrum antibacterial action, while Boric Acid and Sodium Chloride help in cleansing and soothing the ocular surface. Zinc Sulfate adds astringent and supportive anti-inflammatory benefits, enhancing overall treatment effectiveness.
Clinically, Eyenote Plus Eye Drops are widely prescribed for conjunctivitis, mild to moderate eye infections, and irritated eyes, offering balanced infection control with improved patient comfort.
From a business perspective, Eyenote Plus Eye Drops fit perfectly into the antibacterial ophthalmic segment, delivering steady prescription demand, repeat sales, and strong margins. Offered at a best price for PCD pharma franchise, it is a high-rotation product for distributors and franchise partners.